M. Khadige

Centre Georges François Leclerc

Papers

1

Total Citations

6

H-Index

1

About

M. Khadige is a clinical researcher whose work centers on advancing stereotactic body radiation therapy (SBRT) for thoracic oncology, with a particular focus on optimizing treatment protocols for lung cancer and pulmonary oligometastases. In their most cited study, a 2023 cohort investigation, Khadige addressed a critical clinical question: whether fiducial marker implantation remains necessary for CyberKnife® robotic SBRT. By comparing local control and overall survival rates between patients treated with and without prior fiducial placement, their work provided evidence that may streamline treatment workflows and reduce procedural invasiveness. This contribution, garnering 6 citations, holds practical significance for radiation oncologists seeking to balance precision with patient comfort. Khadige’s research sits at the intersection of technological refinement and clinical outcomes, demonstrating a commitment to evidence-based improvements in cancer care. Their findings offer valuable guidance for clinicians navigating the evolving landscape of stereotactic radiation, making their work a reference point for studies on treatment optimization and biomarker-free targeting in thoracic malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
CyberKnife® stereotactic radiation therapy for stage I lung cancer and pulmonary oligometastases: is fiducial implantation still relevant?—a cohort study
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Centre Georges François Leclerc

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago